Advanced Enzymes has made a super duper debut on the market today. Getting listed on the BSE at Rs.1210, this was a fantastic 35% premium over the IPO price of Rs.896/share.

The IPO was a huge hit with its getting subscribed 116 times at this upper price band. The QIB portion was subscribed over 94 times but the biggest response was from HNIs, which was subscribed by an unbelievable 393 times. The retail investors also responded well with their portion subscribing almost 12 times.

In our New Issue Analysis, we had said, “To conclude, issue is seen reasonably priced, with scope for capital appreciation and listing gains seen as well valued attractively and investment is advised.”